Diluted earnings (loss) per share for the three months ended March 31, 2025 and 2024 includes the effect of potential common shares issuable when dilutive, and is as follows: | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | | | 2025 | | 2024 | | | | | | Net income (loss) | | $ | (4,312) | | | $ | 2,939 | | | | | | | Net income (loss) from continuing operations | | (3,139) | | | 1,446 | | | | | | | Net income (loss) from discontinued operations | | (1,173) | | | 1,493 | | | | | | | Weighted average number of common shares outstanding (in '000s) | | 33,693 | | | 33,325 | | | | | | | Dilutive effect of restricted stock grants after application of the Treasury Stock Method (in '000s) | | — | | | 78 | | | | | | | Dilutive shares outstanding | | 33,693 | | | 33,403 | | | | | | | Basic earnings (loss) per share from continuing operations | | $ | (0.09) | | | $ | 0.05 | | | | | | | Basic earnings (loss) per share from discontinued operations | | $ | (0.03) | | | $ | 0.04 | | | | | | | Diluted earnings (loss) per share from continuing operations | | $ | (0.09) | | | $ | 0.05 | | | | | | | Diluted earnings (loss) per share from discontinued operations | | $ | (0.03) | | | $ | 0.04 | | | | | |
|